Drug Interaction with Pristinamycin in a Kidney and Pancreas Transplant Patient
نویسندگان
چکیده
منابع مشابه
Drug Interaction with Pristinamycin in a Kidney and Pancreas Transplant Patient
We report the case of a 49-year-old renal and pancreatic female transplant recipient, who presented a drug interaction between tacrolimus, warfarin and pristinamycin. Three days after oral pristinamycin 1000 mg bid administrations, the patient presented nausea, vomiting, abdominal pain and violent headaches that required hospitalization. Tacrolimus trough level was 5 times higher (34.9 μg/l) th...
متن کاملDiabetic Ketoalkalosis after Steroid Pulse Therapy in a Patient with Pancreas Transplant Rejection
Diabetic ketoacidosis (DKA) is characterized by excessive production of organic acids leading to a low blood pH. Rarely, because of other complicating factors blood pH may be in the alkalemic range and the term diabetic ketoalkalosis has been coined to describe this condition. So far, less than 30 such cases have been reported in the literature. We report a 34-year-old woman who received methyl...
متن کاملDrug Interaction between Sirolimus and Ranolazine in a Kidney Transplant Patient
Purpose. The case of a kidney transplant recipient who experienced a probable drug interaction between sirolimus and ranolazine is reported. Summary. The narrow therapeutic window of immunosuppressive therapy in transplant recipients requires close monitoring for potential drug-drug interactions. The patient, a 57-year-old Caucasian male kidney transplant recipient, was stable for years on siro...
متن کاملNocardiosis in a Kidney-Pancreas Transplant
34-year-old man with chronic renal and pancreas failure in complicated diabetic disease received a kidney-pancreas transplantation. On the 32nd postoperative day, an acute kidney rejection occurred and resolved with OKT3 therapy. The patient also presented refractory urinary infection by E. Fecalis and M. Morganii, and a focal bronchopneumonia in the right-basal lobe resolved with elective chem...
متن کاملIntractable ascites associated with mycophenolate in a simultaneous kidney-pancreas transplant patient: a case report
BACKGROUND Mycophenolic acid (MPA), either given as an ester pro-drug or as an enteric-coated sodium salt, is the most commonly prescribed anti-proliferative immunosuppressive agent used following organ transplantation and widely applied in immune-mediated diseases. Clinicians are well aware of common adverse reactions related to MPA treatment, in particular diarrhea, leukopenia and infections....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Nephrology & Therapeutics
سال: 2013
ISSN: 2161-0959
DOI: 10.4172/2161-0959.s4-009